The Johns Hopkins Division of Cardiac Surgery is ranked among the top programs in the nation. In fiscal year 2025, The Johns Hopkins Hospital performed more cardiac surgery procedures than any other hospital in the state. With the highest volume mitral valve surgery program in the mid-Atlantic, our team is one of the few centers of excellence to receive the Mitral Valve Repair Reference Center Award, presented by the American Heart Association and the Mitral Foundation.

With more adults than children living in the United States with congenital heart disease, our Adult Congenital Heart Surgery Program cares for survivors as they age. While some patients are newly diagnosed, the majority suffer from potential residual lesions or sequelae from previous operations and require multiple surgeries over the course of their lifetime. Leveraging the expertise of our expert diagnostic, heart failure and aortic programs, this comprehensive center, accredited by the Adult Congenital Heart Association, helps ensure that patients of any age are offered state-of-the-art lifelong interventions and care.

Our coronary artery bypass graft (CABG) program offers multiarterial grafting, minimally invasive direct CABG (MIDCAB) and off-pump CABG. We offer pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension and surgical myectomy for patients with obstructive hypertrophic cardiomyopathy. Our surgeons also have expertise in robotic minimally invasive left atrial appendage occlusion as well as treatment of complex heart tumors.

There are several novel advancements in the works that the team is eager to share. Johns Hopkins is the only institution to offer aortic valve bypass surgery for high-risk aortic stenosis patients who are not suitable for TAVR, or in whom TAVR has failed. As part of the Cardiothoracic Surgery Trials Network (CTSN), we are participating in an NHLBI-sponsored randomized trial that compares surgery with catheter transcatheter mitral valve repair.

Key criteria include a >95% repair rate for degenerative disease, <1% operative mortality, a high volume of procedures, and a dedicated multidisciplinary heart team.

The Broccoli Aortic Center

The Johns Hopkins Broccoli Aortic Center provides comprehensive multispecialty care for people with complex aortic conditions. Our world-class experts in cardiology, heart and vascular surgery, genet­ics and radiology combine their expertise to offer tailored treatment approaches, including innovative surgical techniques. Our team’s advanced training and experience often allow us to offer treatments that may not be available elsewhere.

The Broccoli Aortic Center is one of the few centers in the world that can treat patients with acute type A aortic dissection using endovascular aortic root repair, an investigative procedure known as Endo-Bentall repair, pioneered by the center’s co-director Mehrdad Ghoreishi. We deliver rapid, coordinated and high-level care for complex aortic emergencies. The Broccoli Aortic Center is excited to share that Johns Hopkins is the only institution in the region that is participating in three FDA trials using new stent grafts for hybrid (two active trials), as well as endovascular repair (one active trial) for aneurysm repair located in the ascending aorta or aortic arch.

Cardiac Surgery at Suburban Hospital

Hanghang Wang is a cardiac surgeon at Johns Hopkins’ Suburban Hospital and an assistant professor of surgery at the Johns Hopkins University School of Medicine. Her clinical practice includes coronary artery bypass surgery, advanced valve surgery including mitral valve repair, and aortic surgery, bringing academic cardiac surgical expertise to the community setting. As part of the Johns Hopkins heart and vascular service line, she is helping strengthen and grow the cardiac surgery program at Suburban while maintaining close integration with the broader Johns Hopkins cardiac surgery team. Her work emphasizes evidence-based, patient-centered care and high clinical quality.